دورية أكاديمية
أعرض في EDS

Dendritic cells, macrophages, NK and CD8 + T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B.

التفاصيل البيبلوغرافية
العنوان: Dendritic cells, macrophages, NK and CD8 + T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B.
المؤلفون: Lucinda N; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Figueiredo MM; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Pessoa NL; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Santos BS; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Lima GK; Escola de Veterinária, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, 31270-901, MG, Brazil., Freitas AM; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Machado AM; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Kroon EG; Laboratório de Vírus, Departamento de Microbiologia, Universidade Federal de Minas Gerais, Avenida Antônio Carlos 6627, Belo Horizonte, 31270-901, MG, Brazil., Antonelli LR; Biologia e Imunologia Parasitária, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil., Campos MA; Imunologia de Doenças Virais, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Fiocruz, Avenida Augusto de Lima 1715, Belo Horizonte, 30190-002, MG, Brazil. marcoasc@cpqrr.fiocruz.br.
المصدر: Virology journal [Virol J] 2017 Feb 21; Vol. 14 (1), pp. 37. Date of Electronic Publication: 2017 Feb 21.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X (Electronic) Linking ISSN: 1743422X NLM ISO Abbreviation: Virol J Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [London] : BioMed Central, 2004-
مواضيع طبية MeSH: CD8-Positive T-Lymphocytes/*immunology , Dendritic Cells/*immunology , Herpesvirus 1, Human/*immunology , Killer Cells, Natural/*immunology , Macrophages/*immunology , Trigeminal Ganglion/*immunology , Trigeminal Ganglion/*virology, Animals ; Flow Cytometry ; Granzymes/metabolism ; Humans ; Interferon Type I/metabolism ; Interleukin-1beta/metabolism ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Nitric Oxide Synthase Type II/metabolism ; Toll-Like Receptor 2/deficiency ; Toll-Like Receptor 2/metabolism ; Toll-Like Receptor 9/deficiency ; Toll-Like Receptor 9/metabolism
مستخلص: Background: Herpes simplex virus type 1 (HSV-1) cause not only mild symptoms but also blindness and encephalitis. It was previously shown that the immune response against HSV-1 occurs mainly in the trigeminal ganglia (TG) and that Toll-like receptors 2 and 9 (TLR2/9) are important in mediating this response. It was also demonstrated that iNOS (nitric oxide synthase) and interleukin 1 beta (IL-1β) play an essential role in the defense against HSV-1 infection. Importantly, the present work aimed to identify the primary cells responsible for iNOS and IL-1β production and search for other important molecules and cells that might or might not depend on TLR2/9 receptors to mediate the immune response against HSV-1.
Methods: C57BL/6 (wild type, WT) and TLR2/9 -/- mice were infected by the intranasal route with HSV-1 (1 × 10 6 p.f.u.). Cells were obtained from the TG and spleen tissues and the profile of immune cells was determined by flow cytometry in infected and mock infected WT and knockout mice. The percentage of cells producing iNOS, IL-1β, granzyme B and perforin was also determined by flow cytometry. Chemokine monocyte chemoattractant protein-1 (MCP1) was measured by Cytometric Bead Array (CBA) in the TG, spleen and lung. Expression of type I interferons (IFNs), interleukins (IL) 5 and 10, IL-1β and granzyme B were quantified by real time PCR.
Results: The results indicate that dendritic cells (DCs) and monocytes/macrophages (Mo/Mϕ) were the main sources of IL-1β and iNOS, respectively, which, together with type I IFNs, were essential for the immune response against HSV-1. Additionally, we showed that granzyme B produced by CD8 + T and NK lymphocytes and MCP-1 were also important for this immune response. Moreover, our data indicate that the robust production of MCP-1 and granzyme B is either TLR-independent or down regulated by TLRs and occurs in the TG of TLR2/9 -/- infected mice.
Conclusion: Taken together, our data provide strong evidence that the responses mediated by DCs, Mo/Mϕ, NK and CD8 + T lymphocytes through IL-1β, iNOS and granzyme B production, respectively, together with the production of type I IFN early in the infection, are crucial to host defense against HSV-1.
References: Immunity. 2013 Dec 12;39(6):1003-18. (PMID: 24332029)
J Immunol. 2004 May 15;172(10):6020-9. (PMID: 15128785)
Immunol Rev. 2010 May;235(1):35-54. (PMID: 20536554)
Curr Opin Immunol. 2002 Aug;14(4):432-6. (PMID: 12088676)
Methods. 2001 Dec;25(4):386-401. (PMID: 11846608)
J Virol. 2012 Feb;86(4):2273-81. (PMID: 22171256)
Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17343-8. (PMID: 17085599)
J Exp Med. 2005 Aug 1;202(3):425-35. (PMID: 16061729)
Clin Exp Allergy. 2010 Apr;40(4):563-75. (PMID: 20447076)
Immunity. 2009 May;30(5):646-55. (PMID: 19464987)
Clin Vaccine Immunol. 2008 Dec;15(12):1859-67. (PMID: 18971304)
Immunity. 2006 Sep;25(3):373-81. (PMID: 16979569)
Annu Rev Immunol. 2002;20:197-216. (PMID: 11861602)
Glia. 2004 Sep;47(4):358-66. (PMID: 15293233)
Nat Immunol. 2015 Apr;16(4):343-53. (PMID: 25789684)
Brain Res. 2006 Nov 29;1122(1):201-8. (PMID: 17046730)
J Virol. 2008 Nov;82(22):11073-83. (PMID: 18614643)
Virol J. 2005 Aug 03;2:59. (PMID: 16076403)
J Immunol. 2011 Dec 15;187(12):6301-9. (PMID: 22084442)
J Clin Invest. 2011 Dec;121(12):4889-902. (PMID: 22105173)
J Virol. 2008 Oct;82(19):9678-88. (PMID: 18667492)
J Immunol. 2008 Dec 1;181(11):7985-93. (PMID: 19017990)
J Gen Virol. 1998 Apr;79 ( Pt 4):825-30. (PMID: 9568978)
Nat Rev Immunol. 2011 Feb;11(2):143-54. (PMID: 21267015)
PLoS One. 2014 Apr 02;9(4):e93444. (PMID: 24695322)
Annu Rev Immunol. 2001;19:683-765. (PMID: 11244051)
PLoS Pathog. 2015 Jul 08;11(7):e1005028. (PMID: 26153886)
Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1315-20. (PMID: 14739339)
J Neuroimmunol. 2011 May;234(1-2):103-8. (PMID: 21470697)
Virus Res. 2014 Feb 13;180:49-58. (PMID: 24374267)
J Neuroinflammation. 2008 Feb 26;5:7. (PMID: 18302763)
Trends Mol Med. 2012 Dec;18(12):732-41. (PMID: 23099058)
J Virol. 2003 Sep;77(18):10037-46. (PMID: 12941914)
J Immunol. 1994 Sep 1;153(5):2258-65. (PMID: 8051423)
Curr Opin Virol. 2011 Dec;1(6):476-86. (PMID: 22323926)
J Pharm Sci. 2010 Apr;99(4):1654-73. (PMID: 19877171)
PLoS Pathog. 2010 Jul 29;6(7):e1000937. (PMID: 20686655)
Nat Rev Immunol. 2015 May;15(5):271-82. (PMID: 25882242)
J Infect Dis. 2007 Sep 15;196(6):853-60. (PMID: 17703415)
Science. 2008 Oct 10;322(5899):268-71. (PMID: 18845757)
Am J Respir Cell Mol Biol. 2004 Jul;31(1):62-8. (PMID: 14975941)
J Virol. 2000 Jan;74(2):1029-32. (PMID: 10623769)
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7835-40. (PMID: 16682623)
Curr Top Microbiol Immunol. 2006;303:47-65. (PMID: 16570856)
Nat Immunol. 2001 Oct;2(10):907-16. (PMID: 11577346)
Nat Rev Immunol. 2002 Oct;2(10):735-47. (PMID: 12360212)
J Immunol. 2008 May 1;180(9):6297-306. (PMID: 18424753)
J Oral Pathol Med. 2008 Feb;37(2):107-21. (PMID: 18197856)
Immunity. 2014 May 15;40(5):642-56. (PMID: 24837101)
J Neurosci. 2001 Sep 15;21(18):7046-52. (PMID: 11549714)
Mem Inst Oswaldo Cruz. 1998 Mar-Apr;93(2):213-4. (PMID: 9698896)
Mod Rheumatol. 2005;15(5):315-22. (PMID: 17029086)
J Virol. 2009 Feb;83(4):1952-61. (PMID: 19073735)
Eur J Neurosci. 2002 Jul;16(1):29-43. (PMID: 12153529)
Blood. 2004 Feb 1;103(3):1099-104. (PMID: 14512315)
Annu Rev Immunol. 2009;27:519-50. (PMID: 19302047)
Am J Pathol. 2005 May;166(5):1419-26. (PMID: 15855642)
Neurology. 2014 Nov 18;83(21):1888-97. (PMID: 25339207)
Odontology. 2010 Feb;98(1):26-30. (PMID: 20155504)
J Immunol. 2008 Dec 15;181(12):8604-12. (PMID: 19050280)
Biomed Res Int. 2015;2015:327470. (PMID: 26583100)
J Neurovirol. 2013 Aug;19(4):328-45. (PMID: 23943467)
Am J Pathol. 2010 Nov;177(5):2433-45. (PMID: 20864677)
Viruses. 2009 Dec;1(3):979-1002. (PMID: 21994578)
Science. 2006 Oct 13;314(5797):308-12. (PMID: 16973841)
Viruses. 2009 Dec;1(3):737-59. (PMID: 21994567)
Annu Rev Immunol. 2011;29:71-109. (PMID: 21166540)
Nat Rev Immunol. 2011 Oct 14;11(11):723-37. (PMID: 21997792)
Nat Rev Immunol. 2007 Jun;7(6):425-8. (PMID: 17525751)
Virol J. 2016 Mar 08;13:38. (PMID: 26952111)
Int Immunol. 2009 Dec;21(12):1303-9. (PMID: 19819937)
J Exp Med. 2015 Aug 24;212(9):1371-9. (PMID: 26216125)
Clin Microbiol Rev. 2014 Oct;27(4):691-726. (PMID: 25278572)
J Med Virol. 2004 Jun;73(2):313-22. (PMID: 15122810)
Blood. 2006 Feb 1;107(3):1031-8. (PMID: 16219801)
Science. 2007 Sep 14;317(5844):1522-7. (PMID: 17872438)
Cell. 2000 Oct 27;103(3):491-500. (PMID: 11081635)
Immunol Rev. 2000 Feb;173:17-26. (PMID: 10719664)
Mediators Inflamm. 2015;2015:593757. (PMID: 25918478)
Curr Neurol Neurosci Rep. 2013 Dec;13(12):414. (PMID: 24142852)
J Virol. 1999 Mar;73(3):2527-36. (PMID: 9971838)
J Neuroinflammation. 2014 Jan 30;11:20. (PMID: 24479442)
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11416-21. (PMID: 15272082)
Blood. 2004 Feb 15;103(4):1433-7. (PMID: 14563635)
J Virol. 2000 Dec;74(24):11832-40. (PMID: 11090183)
J Immunol. 1999 Mar 1;162(5):2895-905. (PMID: 10072539)
فهرسة مساهمة: Keywords: CD8+ T lymphocytes; Dendritic cells; Encephalitis; Herpes simplex virus 1; Innate immunity; Macrophages; Murine model; Neuropathogenesis; TLRs
المشرفين على المادة: 0 (Interferon Type I)
0 (Interleukin-1beta)
0 (Tlr2 protein, mouse)
0 (Tlr9 protein, mouse)
0 (Toll-Like Receptor 2)
0 (Toll-Like Receptor 9)
EC 1.14.13.39 (Nitric Oxide Synthase Type II)
EC 1.14.13.39 (Nos2 protein, mouse)
EC 3.4.21.- (Granzymes)
EC 3.4.21.- (Gzmb protein, mouse)
تواريخ الأحداث: Date Created: 20170223 Date Completed: 20170823 Latest Revision: 20181113
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC5320739
DOI: 10.1186/s12985-017-0692-x
PMID: 28222752
قاعدة البيانات: MEDLINE
الوصف
تدمد:1743-422X
DOI:10.1186/s12985-017-0692-x